PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria

• Egile Nagusiak: Elise Oh (Egilea), Russ Wada (Egilea), Kha Le (Egilea), Yanan Zheng (Egilea), Jin Jin (Egilea), Victor Poon (Egilea), Kit Wong (Egilea), Ryan Owen (Egilea), Kenta Yoshida (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2023-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract The pharmacokinetic (PK) characteristics of omalizumab and its pharmacodynamic (PD) effect in patients has yet to be fully characterized in chronic spontaneous urticaria, which could elucidate its pathogenesis and treatment response. This study has two objectives; (1) characterize the popul...